271 related articles for article (PubMed ID: 37754852)
21. Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges.
Bose RJC; Ravikumar R; Karuppagounder V; Bennet D; Rangasamy S; Thandavarayan RA
Drug Discov Today; 2017 Aug; 22(8):1258-1265. PubMed ID: 28600191
[TBL] [Abstract][Full Text] [Related]
22. Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.
Khan MM; Madni A; Tahir N; Parveen F; Khan S; Jan N; Ali A; Abdurrahim M; Farooq U; Khan MI
Int J Nanomedicine; 2020; 15():2207-2217. PubMed ID: 32280215
[TBL] [Abstract][Full Text] [Related]
23. Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy.
Jadon RS; Sharma G; Garg NK; Tandel N; Gajbhiye KR; Salve R; Gajbhiye V; Sharma U; Katare OP; Sharma M; Tyagi RK
Colloids Surf B Biointerfaces; 2021 Jul; 203():111760. PubMed ID: 33872827
[TBL] [Abstract][Full Text] [Related]
24. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
Garg NK; Tandel N; Jadon RS; Tyagi RK; Katare OP
Drug Discov Today; 2018 Sep; 23(9):1610-1621. PubMed ID: 29857164
[TBL] [Abstract][Full Text] [Related]
25. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
26. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
Devrim B; Kara A; Vural İ; Bozkır A
Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
[TBL] [Abstract][Full Text] [Related]
27. Lipid-core/polymer-shell hybrid nanoparticles: synthesis and characterization by fluorescence labeling and electrophoresis.
Bou S; Wang X; Anton N; Bouchaala R; Klymchenko AS; Collot M
Soft Matter; 2020 May; 16(17):4173-4181. PubMed ID: 32286601
[TBL] [Abstract][Full Text] [Related]
28. Screening strategies for surface modification of lipid-polymer hybrid nanoparticles.
Rouco H; García-García P; Évora C; Díaz-Rodríguez P; Delgado A
Int J Pharm; 2022 Aug; 624():121973. PubMed ID: 35811041
[TBL] [Abstract][Full Text] [Related]
29. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
30. Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications.
Dave V; Tak K; Sohgaura A; Gupta A; Sadhu V; Reddy KR
J Microbiol Methods; 2019 May; 160():130-142. PubMed ID: 30898602
[TBL] [Abstract][Full Text] [Related]
31. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.
Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP
Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643
[TBL] [Abstract][Full Text] [Related]
33. Polymeric Lipid Hybrid Nanoparticles (PLNs) as Emerging Drug Delivery Platform-A Comprehensive Review of Their Properties, Preparation Methods, and Therapeutic Applications.
Sivadasan D; Sultan MH; Madkhali O; Almoshari Y; Thangavel N
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452251
[TBL] [Abstract][Full Text] [Related]
34. Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy.
Mohanty A; Uthaman S; Park IK
Molecules; 2020 Sep; 25(19):. PubMed ID: 32977707
[TBL] [Abstract][Full Text] [Related]
35. Topical Application of Vitamin D
Pukale SS; Mittal A; Chitkara D
AAPS PharmSciTech; 2021 Sep; 22(7):238. PubMed ID: 34561775
[TBL] [Abstract][Full Text] [Related]
36. Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method.
Fang RH; Aryal S; Hu CM; Zhang L
Langmuir; 2010 Nov; 26(22):16958-62. PubMed ID: 20961057
[TBL] [Abstract][Full Text] [Related]
37. Conventional and microfluidic methods: Design and optimization of lipid-polymeric hybrid nanoparticles for gene therapy.
González-García D; Tapia O; Évora C; García-García P; Delgado A
Drug Deliv Transl Res; 2024 Jun; ():. PubMed ID: 38872047
[TBL] [Abstract][Full Text] [Related]
38. A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells.
Chen C; Sun J; Chen S; Liu Y; Zhu S; Wang Z; Chang S
Int J Nanomedicine; 2019; 14():753-769. PubMed ID: 30718954
[TBL] [Abstract][Full Text] [Related]
39. Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system.
Dave V; Yadav RB; Kushwaha K; Yadav S; Sharma S; Agrawal U
Bioact Mater; 2017 Dec; 2(4):269-280. PubMed ID: 29744436
[TBL] [Abstract][Full Text] [Related]
40. Inhalable Formulation Based on Lipid-Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast.
Craparo EF; Cabibbo M; Scialabba C; Giammona G; Cavallaro G
Biomacromolecules; 2022 Aug; 23(8):3439-3451. PubMed ID: 35899612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
